Effects of TAK-063 on Preventing Ketamine-Induced Brain Activity Changes as Well as Psychotic-Like Symptoms in Healthy Male Adults
Clinical trial NCT01892189 · COMPLETED
Trial details
- NCT number
- NCT01892189
- Sponsor
- Takeda
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-08-01
- Primary completion
- 2014-08-01
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.